Wheatley-Price, Paul <br/><br/>
The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  May 2010 
 - 640-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0b013e3181d40a1b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Canada<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Clinical Trials, Phase III as Topic<br/>Female<br/>Humans<br/>Lung Neoplasms--mortality<br/>Male<br/>Neoplasm Staging<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Retrospective Studies<br/>Sex Factors<br/>Treatment Outcome